Request Deal Involvement
Cormorant Asset Management, HBM Healthcare Investments and Octagon Capital led a $200m Series C round in NiKang Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
legal advisors
Sidley Austin
or
Principals
bidder
SURVEYOR CAPITAL
target
NIKANG THERAPEUTICS
bidder
OCTAGON CAPITAL
bidder
SAMSARA BIOCAPITAL
bidder
HBM HEALTHCARE INVESTMENTS
bidder
WELLINGTON MANAGEMENT
bidder
CORMORANT ASSET MANAGEMENT
bidder
PAVILION CAPITAL
bidder
ALLY BRIDGE GROUP
bidder
LOGOS CAPITAL
bidder
ECOR1 CAPITAL
bidder
PERCEPTIVE ADVISORS LLC
bidder
BLACKROCK
bidder
RA CAPITAL MANAGEMENT
bidder
PFM HEALTH SCIENCES
bidder
THE INVUS GROUP LLC
bidder
JANUS HENDERSON INVESTORS
bidder
CBC GROUP
bidder
RTW INVESTMENTS
bidder
LILLY ASIA VENTURES
bidder
MATRIX PARTNERS
bidder
CASDIN CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite